Further delineation of the NTHL1 associated syndrome: A report from the French Oncogenetic Consortium.

MLA

Boulouard, Flavie, et al. “Further Delineation of the NTHL1 Associated Syndrome: A Report from the French Oncogenetic Consortium.” Clinical Genetics, vol. 99, no. 5, May 2021, pp. 662–72. EBSCOhost, https://doi.org/10.1111/cge.13925.

APA

Boulouard, F., Kasper, E., Buisine, M.-P., Lienard, G., Vasseur, S., Manase, S., Bahuau, M., Barouk Simonet, E., Bubien, V., Coulet, F., Cusin, V., Dhooge, M., Golmard, L., Goussot, V., Hamzaoui, N., Lacaze, E., Lejeune, S., Mauillon, J., Beaumont, M.-P., … Baert-Desurmont, S. (2021). Further delineation of the NTHL1 associated syndrome: A report from the French Oncogenetic Consortium. Clinical Genetics, 99(5), 662–672. https://doi.org/10.1111/cge.13925

Chicago

Boulouard, Flavie, Edwige Kasper, Marie-Pierre Buisine, Gwendoline Lienard, Stéphanie Vasseur, Sandrine Manase, Michel Bahuau, et al. 2021. “Further Delineation of the NTHL1 Associated Syndrome: A Report from the French Oncogenetic Consortium.” Clinical Genetics 99 (5): 662–72. doi:10.1111/cge.13925.